John C Thomas
Director at Dogwood Therapeutics, Inc. (DWTX)
John C Thomas has filed 9 insider reports with the SEC since June 2021, as director at Dogwood Therapeutics, Inc. (DWTX) and insider at ImmunityBio, Inc. (IBRX). John C Thomas made no open-market purchases or sales in the last 12 months. The latest filing, on June 17, 2026, reports grant or award at Dogwood Therapeutics, Inc. (DWTX).
- Filings
- 9
- Companies
- 2
- Bought on market
- $5,650
- Sold on market
- None
Companies where John C Thomas is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 1,000 | $5,650 | $5.65 | $1.06-81% | Jun 17, 2026 | ||
| Insider | 202,477 | $6.57 | Jan 28, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 16, 2026DWTXSEC Form 4 filed by Director Thomas John CForm 4Grant or award
- Jun 27, 2025DWTXSEC Form 4 filed by Director Thomas John CForm 4Grant or award
- Jun 18, 2025DWTXSEC Form 4 filed by Director Thomas John CForm 4Grant or award
- Feb 26, 2024DWTXSEC Form 4 filed by Thomas John CForm 4Grant or award
- Jun 15, 2023DWTXSEC Form 4 filed by Thomas John CForm 4Grant or award
- Jun 23, 2022DWTXSEC Form 4 filed by Thomas John CForm 4Grant or award
- Feb 23, 2021IBRXSEC Form 5: Thomas John C gifted 5,000 shares, decreasing direct ownership by 2% to 202,477 unitsForm 5Gift
- Jan 4, 2022+$5,650DWTXSEC Form 4: Thomas John C bought $5,650 worth of shares (1,000 units at $5.65)Form 4Open-market purchase
Compare John C Thomas with
- John C Thomas vs Cheryl Cohen1 shared
- John C Thomas vs Christobel Selecky1 shared
- John C Thomas vs Barry J. Simon1 shared
- John C Thomas vs Abel De La Rosa1 shared
- John C Thomas vs Richard James Whitley1 shared
- John C Thomas vs David R Keefer1 shared
Other insiders at the same companies
- Cheryl CohenIBRX
- Christobel SeleckyIBRX
- Barry J. SimonIBRX
- Abel De La RosaDWTX
- Richard James WhitleyDWTX
- David R KeeferDWTX
- Michael D BlaszykIBRX
- Bruce WendelIBRX
- Linda MaxwellIBRX
- Wesley ClarkIBRX
- Patrick Soon-ShiongIBRX
- Ralph GrosswaldDWTX
- Angela WalshDWTX
- Roger Michael GendreauDWTX
- Gregory Scott DuncanDWTX
- David C. SachsIBRX
Questions about John C Thomas
- What is John C Thomas's role at Dogwood Therapeutics, Inc.?
- John C Thomas reports to the SEC as director at Dogwood Therapeutics, Inc. (DWTX), according to the latest filing on June 17, 2026. John C Thomas has also filed as insider at ImmunityBio, Inc. (IBRX).
- How many shares does John C Thomas own?
- After the latest filing that states it, John C Thomas directly owned 1,000 shares of Dogwood Therapeutics, Inc. (DWTX) and 202,477 shares of ImmunityBio, Inc. (IBRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has John C Thomas bought or sold stock recently?
- The most recent open-market purchase was on January 4, 2022: bought 1,000 shares of Virios Therapeutics, Inc. (DWTX) for $5,650 at an average of $5.65.
- How do I get alerts when John C Thomas files?
- Follow John C Thomas on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by John C Thomas (SEC CIK 0001424620). Totals count each trade once, skipping amendments whose original is on file, from Jun 23, 2021 on. View on SEC EDGAR · Get this as JSON